Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce ...

Medical and health news service that features the most comprehensive coverage in the fields of neuroscience, cardiology, cancer, HIV/AIDS, psychology, psychiatry, dentistry, genetics, diseases and ...

Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce structural liver damage and ...

The best-case scenario on alcohol related liver disease is a remission from physical symptoms and a restoration of liver function to a level where the patients can live a life as close to normal as ...

Galectin Therapeutics ( ($GALT) ) has issued an update. On December 19, 2025, Galectin Therapeutics reported that the U.S. Food and Drug ...

Hepatitis B vaccine at birth is safe, effective, and gives long lasting protection from an infection that can have ...

Sagimet Biosciences Inc. stock rated Strong Buy on promising drug data and pipeline growth in acne and MASH. Click for this ...

Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal hypertension ...

The combination of denifanstat and resmetirom was generally well-toleratedPharmacokinetic (PK) results support further ...

Investing.com -- Galectin Therapeutics Inc (NASDAQ:GALT) stock plummets 33.6% in premarket trading Friday after the company received written feedback from the FDA regarding its belapectin development ...

The researchers noted that integrating mental health support into liver disease treatment is a critical step toward protecting veterans from liver cancer.